menu
    • menu

    Company profile for Summit Therapeutics

    NEW Drugs in Dev: 4
    Seqens is an integrated global leader in pharmaceutical solutions & specialty ingredients, & custom-made solutions to our customers.

    Virtual Booth

    Contact Supplier

    AbbVie Contract Manufacturing partners globally to develop, scale, and manufacture pharmaceutical products successfully.

    Virtual Booth

    Contact Supplier

    Topscience Biotech is a one-stop supplier of sodium hyaluronate//drug manufacturing license, CEP, GMP, DMF, and Form 41 certifications.

    Virtual Booth

    Contact Supplier

    Zach System is committed to providing Highly Customized Solutions for all your Development Programs.

    Virtual Booth

    Contact Supplier

    EUROAPI, the leading small molecules API player, provides both API sales & CDMO services.

    Virtual Booth

    Contact Supplier

    pharmacompass-2-m-2026-04-20

    Virtual Booth

    Contact Supplier

    EVENTS

    DIGITAL CONTENT

    DEVELOPMENTS

    REF. STANDARDS & IMPURITIES

    PharmaCompass

    Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth

    Update your Virtual Booth on PharmaCompass, ask us

    About

    We’re developing new mechanism antibiotics to become the new standards of care. We have a clear strategy: through new science and philosophy, we are creating new opportunities to become the standard of care for serious infectious diseases. Our proprietary Discuva Platform is designed to uncover novel bacterial targets and develops new mechanism antibiotics against them. To date, the Discuva Platform has developed two new tar...
    We’re developing new mechanism antibiotics to become the new standards of care. We have a clear strategy: through new science and philosophy, we are creating new opportunities to become the standard of care for serious infectious diseases. Our proprietary Discuva Platform is designed to uncover novel bacterial targets and develops new mechanism antibiotics against them. To date, the Discuva Platform has developed two new targets for gonorrhoea, an ESKAPE programme and undisclosed programmes with Roche.

    List your booth number for exhibitions, ask us

    CONTACT DETAILS

    Click the arrow to open the dropdown
    Contact SupplierContact
    Google MapGoogle Map
    Full View ScreenFull View Screen
    Summit TherapeuticsUnited_States_of_America Flag
    Country
    Country
    U.S.A
    Address
    Address
    2882 Sand Hill Road Suite 106 Menlo Park CA, 94025
    Telephone
    Telephone
    +44 (0)1235 443 939
    Client Email
    Email
    enquiries@pharmacompass.com
    Client Website
    Website
    https://www.summitplc.com/
    Linkedin
    Linkedin
    youtube
    YouTube
    Twitter
    Twitter

    Upload your Marketing & Sales content on your company Virtual Booth, click HERE.

    Events

    Webinars & Exhibitions

    Request a meetingRequest a meeting
    Full Screen ViewFull Screen View
    PEGS Boston Summit

    PEGS Boston Summit

    Not Confirmed

    envelop Contact Supplier

    PEGS Boston Summit

    Post an Enquiry

    Meeting

    Digital content

    Create Content with PharmaCompass, ask us

    NEWS #PharmaBuzz

    read-more
    read-more
    Summit Therapeutics Joins Goldman Sachs Global Health Conference
    Summit Therapeutics Joins Goldman Sachs Global Health Conference

    04 Jun 2026

    // BUSINESSWIRE

    https://www.businesswire.com/news/home/20260604675929/en/Summit-Therapeutics-to-Participate-in-the-47th-Annual-Goldman-Sachs-Global-Healthcare-Conference

    BUSINESSWIRE
    04 Jun 2026
    Share Share
    Ivonescimab + Chemo Beats Tislelizumab + Chemo in Sq NSCLC
    Ivonescimab + Chemo Beats Tislelizumab + Chemo in Sq NSCLC

    31 May 2026

    // BUSINESSWIRE

    https://www.businesswire.com/news/home/20260531161413/en/Ivonescimab-with-Chemotherapy-Demonstrated-a-Statistically-Significant-Overall-Survival-Benefit-Compared-to-Tislelizumab-Plus-Chemotherapy-in-1L-Treatment-of-Patients-with-Squamous-NSCLC-in-the-HARMONi-6-Study-Conducted-by-Akeso-in-China

    BUSINESSWIRE
    31 May 2026
    Share Share
    Akeso's Ivonescimab Cuts Death Risk 34% in Lung Cancer
    Akeso's Ivonescimab Cuts Death Risk 34% in Lung Cancer

    31 May 2026

    // FIERCE PHARMA

    https://www.fiercepharma.com/pharma/asco-akeso-ivonescimab-bests-pd-1-inhibitor-squamous-nsclc-overall-survival

    FIERCE PHARMA
    31 May 2026
    Share Share
    Ivonescimab Phase 2 Shows Promise in First-Line mCRC at ASCO
    Ivonescimab Phase 2 Shows Promise in First-Line mCRC at ASCO

    30 May 2026

    // BUSINESSWIRE

    https://www.businesswire.com/news/home/20260530544179/en/Encouraging-Global-Phase-II-Ivonescimab-Data-in-First-Line-Metastatic-Colorectal-Cancer-Presented-at-ASCO-2026

    BUSINESSWIRE
    30 May 2026
    Share Share
    All Eyes on Revolution & Bispecific Antibodies at ASCO 2026
    All Eyes on Revolution & Bispecific Antibodies at ASCO 2026

    26 May 2026

    // BIOSPACE

    https://www.biospace.com/drug-development/all-eyes-on-revolution-bispecific-antibodies-and-more-at-asco26

    BIOSPACE
    26 May 2026
    Share Share
    #ASCO26: New VEGF Bispecific Data From BioNTech-BMS, Pfizer-3SBio
    #ASCO26: New VEGF Bispecific Data From BioNTech-BMS, Pfizer-3SBio

    21 May 2026

    // ENDPOINTS

    https://endpoints.news/new-data-released-for-vegf-bispecifics-from-biontech-bms-pfizer-3sbio/

    ENDPOINTS
    21 May 2026
    Share Share

    REF. STANDARDS & IMPURITIES

    Upload your portfolio for free, ask us

    ABOUT THIS PAGE

    Ask Us for Pharmaceutical Supplier and Partner
    Ask Us, Find A Supplier / Partner
    No Commissions, No Strings Attached, Get Connected for FREE

    What are you looking for?

    How can we help you?

    The request can't be empty

    Please read our Privacy Policy carefully

    You must agree to the privacy policy

    The name can't be empty
    The company can't be empty.
    The email can't be empty Please enter a valid email.
    The mobile can't be empty
    • Privacy policy
    • Terms and conditions
    • Disclaimers
    • LinkedIn
    • Product listings are provided for informational purposes only. We do not supply or sell any products. Any products that may be covered by patent(s) are supplied solely for uses permitted under Section 107A of the Indian Patents Act and not for commercial sale.

    Market Place

    Market Place

    PharmaCompass

    Home

    Market Place

    Menu

    Post Enquiry

    Post Enquiry

    Market Place

    Market Place

    Search